Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer

Completed · Phase 2

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with metastatic colorectal cancer.

Key facts

Study ID

NCT00003220

Run by

Barbara Ann Karmanos Cancer Institute

Starts

1998-02-01

Expected to finish

2001-06-01

Last updated by the study team

2013-04-05

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Veterans Affairs Medical Center - Detroit — Detroit, Michigan, United States
• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.